122 related articles for article (PubMed ID: 7585070)
21. The Gambian National Impregnated Bed Net Programme: evaluation of effectiveness by means of case-control studies.
D'Alessandro U; Olaleye B; Langerock P; Bennett S; Cham K; Cham B; Greenwood BM
Trans R Soc Trop Med Hyg; 1997; 91(6):638-42. PubMed ID: 9509168
[TBL] [Abstract][Full Text] [Related]
22. The pattern of childhood hepatitis B infection in two Gambian villages.
Whittle H; Inskip H; Bradley AK; McLaughlan K; Shenton F; Lamb W; Eccles J; Baker BA; Hall AJ
J Infect Dis; 1990 Jun; 161(6):1112-5. PubMed ID: 2345294
[TBL] [Abstract][Full Text] [Related]
23. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.
Viviani S; Jack A; Hall AJ; Maine N; Mendy M; Montesano R; Whittle HC
Vaccine; 1999 Aug; 17(23-24):2946-50. PubMed ID: 10462228
[TBL] [Abstract][Full Text] [Related]
25. Cerebral malaria is associated with IgG2 and IgG4 antibody responses to recombinant Plasmodium falciparum RIFIN antigen.
Schreiber N; Brattig N; Evans J; Tsiri Agbenyega ; Horstmann RD; May J; Klinkert MQ
Microbes Infect; 2006 Apr; 8(5):1269-76. PubMed ID: 16679041
[TBL] [Abstract][Full Text] [Related]
26. [Hepatitis B virus and primary glomerulonephritis].
Liu ZH; Li LS
Zhonghua Nei Ke Za Zhi; 1990 Sep; 29(9):522-5. PubMed ID: 2086023
[No Abstract] [Full Text] [Related]
27. Human leucocyte antigen (HLA) and malaria morbidity in a Gambian community.
Bennett S; Allen SJ; Olerup O; Jackson DJ; Wheeler JG; Rowe PA; Riley EM; Greenwood BM
Trans R Soc Trop Med Hyg; 1993; 87(3):286-7. PubMed ID: 8236393
[TBL] [Abstract][Full Text] [Related]
28. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles.
McGuire W; Knight JC; Hill AV; Allsopp CE; Greenwood BM; Kwiatkowski D
J Infect Dis; 1999 Jan; 179(1):287-90. PubMed ID: 9841857
[TBL] [Abstract][Full Text] [Related]
29. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
Taylor RR; Allen SJ; Greenwood BM; Riley EM
Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
[TBL] [Abstract][Full Text] [Related]
30. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis B in children with cancer].
Espinoza Holguin M; Arteaga-Vizcaíno M; Porto L; Montilva R; Atencio R; Diana C; Ferrer O O
Rev Gastroenterol Peru; 2006; 26(3):259-64. PubMed ID: 17053821
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B carriage in children.
Milne A; Moyes CD
N Z Med J; 1983 Apr; 96(729):238-41. PubMed ID: 6572835
[TBL] [Abstract][Full Text] [Related]
33. Assessment of submicroscopic infections and gametocyte carriage of Plasmodium falciparum during peak malaria transmission season in a community-based cross-sectional survey in western Kenya, 2012.
Zhou Z; Mitchell RM; Kariuki S; Odero C; Otieno P; Otieno K; Onyona P; Were V; Wiegand RE; Gimnig JE; Walker ED; Desai M; Shi YP
Malar J; 2016 Aug; 15(1):421. PubMed ID: 27543112
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response.
Inskip HM; Hall AJ; Chotard J; Loik F; Whittle H
Int J Epidemiol; 1991 Sep; 20(3):764-9. PubMed ID: 1835452
[TBL] [Abstract][Full Text] [Related]
35. Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity.
Nielsen MA; Staalsoe T; Kurtzhals JA; Goka BQ; Dodoo D; Alifrangis M; Theander TG; Akanmori BD; Hviid L
J Immunol; 2002 Apr; 168(7):3444-50. PubMed ID: 11907103
[TBL] [Abstract][Full Text] [Related]
36. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B seroprevalence among children in a Turkish hospital.
Cetinkaya F; Gürses N; Oztürk F
J Hosp Infect; 1995 Mar; 29(3):217-9. PubMed ID: 7615939
[TBL] [Abstract][Full Text] [Related]
38. Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A case-control study of 140 adults and their 603 family contacts.
Ryder RW; Whittle HC; Sanneh AB; Ajdukiewicz AB; Tulloch S; Yvonnet B
Am J Epidemiol; 1992 Nov; 136(9):1122-31. PubMed ID: 1334367
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage.
Mendy ME; Fortuin M; Hall AJ; Jack AD; Whittle HC
Br J Biomed Sci; 1999; 56(1):34-8. PubMed ID: 10492913
[TBL] [Abstract][Full Text] [Related]
40. Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among Senegalese children.
Males S; Gaye O; Garcia A
Clin Infect Dis; 2008 Feb; 46(4):516-22. PubMed ID: 18199040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
